3-Bromo-1-(3-chloropyridin-2-yl)-N-(2-methyl-6-(methylcarbamoyl)phenyl)-1H-pyrazole-5-carboxamide

Catalog No. :
ACJLPP059
CAS No. :
500007-36-3
Molecular Formula :
C18H15BrClN5O2
Molecular Weight :
448.71

IUPAC Name:3-bromo-1-(3-chloropyridin-2-yl)-N-(2-methyl-6-(methylcarbamoyl)phenyl)-1H-pyrazole-5-carboxamide

3-Bromo-1-(3-chloropyridin-2-yl)-N-(2-methyl-6-(methylcarbamoyl)phenyl)-1H-pyrazole-5-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$746.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Bromo-1-(3-chloropyridin-2-yl)-N-(2-methyl-6-(methylcarbamoyl)phenyl)-1H-pyrazole-5-carboxamide
IUPAC Name3-bromo-1-(3-chloropyridin-2-yl)-N-(2-methyl-6-(methylcarbamoyl)phenyl)-1H-pyrazole-5-carboxamide
Molecular FormulaC18H15BrClN5O2
Molecular Weight448.71
SMILESO=C(C1=CC(Br)=NN1C2=NC=CC=C2Cl)NC3=C(C(NC)=O)C=CC=C3C
InChI KeyOXJFWYQHFMPKQI-UHFFFAOYSA-N
Synonym1H-Pyrazole-5-carboxamide, 3-bromo-1-(3-chloro-2-pyridinyl)-N-[2-methyl-6-[(methylamino)carbonyl]phenyl]-;3-bromo-1-(3-chloropyridin-2-yl)-N-[2-methyl-6-(m ethylcarbamoyl)phenyl]-1H-pyrazole-5-carboxami de;3-Deschloro-4-methyl-Chlorantraniliprole
CAS No.500007-36-3

Synthetic Route by SureRoute

1. ACJLPP059 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDYWP582 route compound structure diagram
    ACDYWP582870997-57-2 In Stock
  2. Plus
  3. ACGOKE053 route compound structure diagram
    ACGOKE053500011-86-9 In Stock
  4. Then
  5. ACJLPP059 route product structure diagram
    ACJLPP059500007-36-3
Inquiry

2. ACJLPP059 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJLPP059 route product structure diagram
    ACJLPP059500007-36-3
Inquiry

Comments (0)